Drug and Medication Analysis & Statistics in Africa Countries, March 2015

1-30 of 96 reports

Purchase Reports From Reputable Market Research Publishers

Nigeria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Nigeria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: As the most populous country on the African continent, Nigeria should be of interest to multinational drugmakers. However, extremely low per capita spending on medicines, rampant counterfeiting ...

  • Industries : Drug and Medication
  • Countries : Nigeria
Algeria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Algeria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: Algeria is a high-risk industry for multinational drugmakers because of the combination of regional uncertainty and state interference in its business environment. The country’s protectionist ...

  • Industries : Drug and Medication
  • Countries : Algeria
Ghana Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Ghana Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Ghana’s pharmaceutical industry is expected to post double-digit year-on-year (y-o-y) growth again in 2011, which will partly be due to inflation. Per capita spending on medicines will remain ...

  • Industries : Drug and Medication
  • Countries : Ghana
South Africa Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

South Africa Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: South Africa's timescale for enacting its National Health Insurance (NHI) scheme is practical and achievable, as are the country’s plans to improve governance, administration and funding. However, ...

  • Industries : Drug and Medication
  • Countries : South Africa
Egypt Pharmaceuticals and Healthcare Report Q1 2015

Egypt Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Recent developments have led us to hold a more positive outlook for Egypt's pharmaceutical and healthcare markets. An increased healthcare budget for 2015, combined with the government's efforts ...

  • Industries : Drug and Medication
  • Countries : Egypt
Morocco Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Morocco Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: According to the figures provided by l’Association Marocaine de l’Industrie Pharmaceutique (AMIP), drug expenditure in Morocco reached a value of MAD9.00bn (US Dollar 1.14bn) in 2010. We ...

  • Industries : Drug and Medication
  • Countries : Morocco
Anti-Infective Drug News 12 JANUARY 2015

Anti-Infective Drug News 12 JANUARY 2015

  • $ 1 114
  • Industry report
  • January 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - High NME FDA Approvals In 2014 Indicates New Era For Anti-Infectives Industry Brief - Xydalba Gains CHMP Positive Opinion For ABSSSIs In Adults Industry Brief - Zevtera Gains ...

  • Industries : Drug and Medication
  • Countries : South Africa, Canada, Africa, World, United States, United Kingdom
Cardiometabolic Drug News DECEMBER 2014

Cardiometabolic Drug News DECEMBER 2014

  • $ 1 114
  • Industry report
  • December 2014
  • by Espicom Business Intelligence

Industry Brief - Analyses Show Novartis' LCZ696 Could Change Course Of HF For Patients Industry Brief - Intarcia/Servier Sign Ex-US Partnership For ITCA 650 In Diabetes Industry Brief - Cardiome/Aspen ...

  • Industries : Drug and Medication
  • Countries : United States, Japan, South Africa, World, Africa, North America
Nigeria: Ginger - Market Report. Analysis and Forecast to 2020

Nigeria: Ginger - Market Report. Analysis and Forecast to 2020

  • $ 1 015
  • Industry report
  • January 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Ginger Market in Nigeria. It presents the latest data of the market value, consumption, domestic production, exports and imports, price dynamics and food ...

  • Industries : Drug and Medication
  • Countries : Nigeria
Synmosa Biopharma Corporation (Symbol:4114) SWOT Analysis, Strategy, Revenues and Profits

Synmosa Biopharma Corporation (Symbol:4114) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Taiwan, South Africa
Fine Chemicals Corporation (Symbol:Pty) SWOT Analysis, Strategy, Revenues and Profits

Fine Chemicals Corporation (Symbol:Pty) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : South Africa
Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company ...

  • Industries : Drug and Medication
  • Countries : India, United States, World, Australia, South Africa, China
CAPS Holdings Limited - Strategic SWOT Analysis Review

CAPS Holdings Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary CAPS Holdings Limited (CAPS) is one of Africa's largest vertically integrated group of pharmaceutical and healthcare companies. The group's marketing, manufacturing, wholesaling, retailing and ...

  • Industries : Drug and Medication
  • Countries : Africa, South Africa, Zimbabwe, Botswana
Emcure Pharmaceuticals Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Emcure Pharmaceuticals Ltd. (Emcure) is a pharmaceutical company. The company develops, manufactures and markets health care products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante, ...

  • Industries : Drug and Medication
  • Countries : India, World, Singapore, South Africa
Nigeria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Nigeria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Uncompetitive local drugmakers in Nigeria can only survive with government intervention or investment. This support has come in the form of the Nigerian Pharmaceutical Development Fund (NPDF) ...

  • Industries : Drug and Medication
  • Countries : Nigeria
Kenya Pharmaceuticals and Healthcare Report Q1 2015

Kenya Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The rising non-communicable disease burden will boost demand for prescription medicines to treat chronic diseases in Kenya. However, we believe drugmakers cannot ...

  • Industries : Drug and Medication
  • Countries : Kenya
Egypt Pharmaceuticals and Healthcare Report Q4 2014

Egypt Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Egypt's relative political stability will lead to a pickup in growth over the coming quarters, increasing the attractiveness of the pharmaceutical market - ...

  • Industries : Drug and Medication
  • Countries : Egypt
Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : South Africa, Africa, Ireland, World, United States
World Generic Markets 20 OCTOBER 2014

World Generic Markets 20 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Leaked TPP Document Reveals Pharmaceutical Policy Disputes Remain Industry Brief - Impax To Acquire Tower Holdings And Subsidiaries Industry Trend Analysis - Congress Probes Generic ...

  • Industries : Drug and Medication
  • Countries : World, South Africa, United States, India, Kenya, Africa
Morocco Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Morocco Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: While the depreciation of the local tender will negatively impact industry growth in US dollar terms, the roll-out of the insurance scheme and the elevated inflation will continue to push up ...

  • Industries : Drug and Medication
  • Countries : Morocco
Ghana Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Ghana Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Globally, Ghana is ranked as the 74th most attractive industry for pharmaceutical business, out of a total of 84 countries surveyed by our proprietary Business Environment Ratings (BER) matrix. ...

  • Industries : Drug and Medication
  • Countries : Ghana
South Africa Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

South Africa Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: South Africa's timescale for enacting its National Health Insurance (NHI) scheme is practical and achievable, as are the country’s goals to improve governance, administration and funding. However, ...

  • Industries : Drug and Medication
  • Countries : South Africa
Analgesics Market Overview in Tunisia

Analgesics Market Overview in Tunisia

  • $ 898
  • Industry report
  • September 2014
  • by Euromonitor International

Acetaminophen continued to enjoy wide popularity in Tunisia, accounting for well over half of all sales of adult analgesics. The product saw several new launches in 2009 from Sanofi-Aventis Pharma Tunisie ...

  • Industries : Drug and Medication
  • Countries : Tunisia
Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Tunisia

Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Tunisia

  • $ 898
  • Industry report
  • September 2014
  • by Euromonitor International

The main event of 2009 was the global warning by the WHO about the H1N1 flu pandemic that hit the world news in summer. Amid widespread global fears of contagion, many Tunisians decided to refill thei ...

  • Industries : Drug and Medication
  • Countries : Tunisia
Bayer Healthcare Maroc in Consumer Health (Morocco)

Bayer Healthcare Maroc in Consumer Health (Morocco)

  • $ 153
  • Company report
  • September 2014
  • by Euromonitor International

Bayer Healthcare Maroc will seek to expand its product offer by tapping into other consumer health categories in which it is not present, such as cough, cold and allergy remedies or categories in which ...

  • Industries : Drug and Medication
  • Countries : Morocco
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Morocco

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Morocco

  • $ 898
  • Industry report
  • September 2014
  • by Euromonitor International

Several combination product brands designed to cure both colds and coughs were introduced in the middle of the review period including Rhumix by Laboratoires Galenica SA, and Rhufene Rhume by Laboratoires ...

  • Industries : Drug and Medication
  • Countries : Morocco
NRT Smoking Cessation Aids Market Analysis in Morocco

NRT Smoking Cessation Aids Market Analysis in Morocco

  • $ 898
  • Industry report
  • September 2014
  • by Euromonitor International

This is due to the fact that and the majority of Moroccan consumers try to stop smoking on their own without the use of these products, which they generally consider to be too expensive and ineffective. ...

  • Industries : Drug and Medication, Tobacco
  • Countries : Morocco
Analgesics Market Overview in Morocco

Analgesics Market Overview in Morocco

  • $ 898
  • Industry report
  • September 2014
  • by Euromonitor International

The economic recession and declining disposable incomes had a negative impact on sales of analgesics as it prompted consumers to cut back on analgesics. Constrained incomes also prompted consumers to trade ...

  • Industries : Drug and Medication
  • Countries : Morocco
Analgesics Market Overview in Algeria

Analgesics Market Overview in Algeria

  • $ 898
  • Industry report
  • September 2014
  • by Euromonitor International

Due to high visibility and consumer awareness and familiarity with such products, systemic analgesics continued to take the biggest share of analgesics in 2009. With DZD14.4 billion, analgesics held the ...

  • Industries : Drug and Medication
  • Countries : Algeria
Cough, Cold and Allergy (Hay Fever) Remedies in Algeria

Cough, Cold and Allergy (Hay Fever) Remedies in Algeria

  • $ 898
  • Industry report
  • September 2014
  • by Euromonitor International

Rising disposable income levels supported sales growth in cough, cold and allergy (hay fever) remedies towards the end of the review period, with consumers benefiting from government pay hikes and more ...

  • Industries : Drug and Medication
  • Countries : Algeria
About 400 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication market shares

  • January 2015
    2 pages
  • Liberia  

    Sierra Leone  

    Guinea  

View report >

Drug Industry In Ghana

January 2015

1 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.